about
Measurement of the Inclusive Electron Neutrino Charged Current Cross Section on Carbon with the T2K Near DetectorPrognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancerTumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesisSmall bowel adenocarcinoma - terra incognita: A demand for cross-national pooling of dataOverexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.[Critical assessment of a new endoscopic anatomic concept for the so-called cardia in the sense of the notions of Parmenides and Martin Heidegger].Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial.The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resection.Lymphangiogenesis, inflammation and metastasis.MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.Targeted therapy in gastric cancer.Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractStrategies for weight regain after sleeve gastrectomy.Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment.Review on the annual cancer risk of Barrett's esophagus in persons with symptoms of gastroesophageal reflux disease.The cardia: esophageal or gastric? Critical reviewing the anatomy and histopathology of the esophagogastric junction.Review on novel concepts of columnar lined esophagus.Upper esophageal sphincter dysfunction: diverticula-globus pharyngeus.Treatment of Barrett's esophagus: update on new endoscopic surgical modalities.Expression of BRAF V600E mutant protein in epithelial ovarian tumors.External validation of the NUn score for predicting anastomotic leakage after oesophageal resection.Targeting HER 2 and angiogenesis in gastric cancer.MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.Waist to hip ratio is a better predictor of esophageal acid exposure than body mass index.Mutant IDH1 inhibits PI3K/Akt signaling in human glioma.Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer.Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass--indications and outcome.Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis.A retrospective study on the safety, diagnostic yield, and therapeutic effects of endoscopic unroofing for small gastric subepithelial tumors.Extending Barrett's esophagus cancer risk profile towards genetic abnormalitiesLevel of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.Lymphovascular invasion of tumor cells in lymph node metastases has a negative impact on survival in esophageal cancer.Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer.Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal CancerAbdominal drainage after liver transplantation from deceased donors.Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma.Surgical treatment of GIST--an institutional experience of a high-volume center.
P50
Q21706448-B5AA4D6D-8042-4207-854D-532611DC21C8Q24540132-BBE20E30-CDAB-4FBF-A4F5-FC2AE46E2F2BQ24669710-49B0E0CD-0208-4FA1-ABDF-1416F57ADF32Q30808696-1E709C3A-6FC5-4D68-9A1C-A5C7D39FF869Q31076492-09721CF6-30BA-44E9-B88C-F54F3960C888Q33395123-2724CE55-F73F-446B-80B2-D322B52AAFC7Q33461284-397C68A7-A750-4707-9FE7-61D9B968AE2DQ34947112-22296901-D157-483B-B117-0DFB168D5B97Q35227504-547C3DED-E8A5-4012-8EC1-D824149A28CEQ35444368-3329B948-F501-4FBF-B4FA-6830051538A2Q35579697-D1CCA7E6-60A0-42F0-BF14-F3CBB0805F2BQ36333735-62AF4B90-5FCF-4535-8754-700DDAE27B3EQ36655845-F95F8C09-FA4D-4BCE-A5C6-8B2FFB4A5BCEQ37341824-DEC18CD5-52C6-4EA7-AE78-1E2DA377086CQ37560857-D21A5A85-586E-43D5-914F-2D89B4CF7984Q37765451-5320DB0C-F9A2-49D9-9D6A-F600A0A50129Q37904277-E6EE9895-34AF-4737-AF50-A6D8EA142824Q38066140-8B41F25A-1C2E-457E-9F18-1CAFD6679182Q38105084-2CDF2EF3-08E2-4AC0-A46B-6BD3F05EAF96Q38141855-D422E38B-01D0-4C6D-BB5A-EB123992BB4FQ38151819-F7485C34-AC60-4C65-903D-E770A99746CEQ38341806-B76CE5DC-8D9B-4293-A441-A06319EB633EQ38402125-DE885881-7FB1-492F-A3EF-64D46942F4ACQ38602997-A77A059E-0BF3-45A1-AB5A-6680183C7BE3Q38633308-2FD6DCAF-D306-47EC-A4F1-6067F927FB04Q38970551-A32AC9C1-B174-4072-827E-6E540678936BQ38992710-BE0F5BA5-877C-4CD2-BDD5-B639E44FE353Q39000847-225C5EAC-2979-45D9-A1DA-197833E463B6Q39063631-A94D4777-CAB3-450B-B7D9-456151DBA6E5Q39287657-E577E23E-5E29-4D3E-8BFB-1F1E58920D14Q39580126-68B052ED-05A3-4FB9-B527-413168C30EC1Q39826524-B2F09158-48FA-46F1-8F7B-7B6477968393Q40536575-13868BEE-3C5B-43FB-9E8E-EF2EE9FA527CQ40606166-689D79D7-2908-4342-BDAB-02639CE3F252Q40796495-CC5FFCB7-814C-4BC4-9897-01AB1F74F187Q40872263-DC6B49E0-3564-412B-99C4-0FC1E1255827Q40979708-EF8BE008-D6C6-487B-BFFF-661E279E682FQ41014998-51A0CB8B-016F-41AA-9706-183663924869Q41204382-0BE17E7B-C5C7-40A1-93EB-4A7389F61FFBQ42616482-6A3D1143-0371-479F-9C7D-138318FAA036
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sebastian F Schoppmann
@ast
Sebastian F Schoppmann
@en
Sebastian F Schoppmann
@es
Sebastian F Schoppmann
@sl
type
label
Sebastian F Schoppmann
@ast
Sebastian F Schoppmann
@en
Sebastian F Schoppmann
@es
Sebastian F Schoppmann
@sl
prefLabel
Sebastian F Schoppmann
@ast
Sebastian F Schoppmann
@en
Sebastian F Schoppmann
@es
Sebastian F Schoppmann
@sl
P1053
K-1530-2017
P106
P21
P31
P3829
P496
0000-0002-1725-7086